Allograft materials have been the mainstay in addressing bone deficiencies in knee and hip replacement and revision surgery for decades because of the associated donor site morbidity of autografts. Bone graft substitutes have been developed to address allograft issues including potential contamination, disease transmission, and availability. Although non-autogenous products have no osteogenic potential, they do have a variable degree of osteoinductive and osteoconductive properties.

Unfortunately, there are limited reports regarding use of bone graft substitutes for use in total hip and knee arthroplasty. Bone graft substitutes have most frequently been used as an “extender”, in combination with morsellised allograft, to fill cavitary defects. Incorporation of this bone graft substitute and morsellised allograft combination appears to occur incompletely. Stable implant fixation appears to be a prerequisite for incorporation of bone graft substitutes, as these cannot be relied upon for structural support. Although bone graft substitutes appear to perform satisfactorily as “fillers” for contained cavitary bone defects, ultraporous metal augments have become the preferred method of providing structural support for some defects. In view of their substantial cost, high quality clinical, radiographic and retrieval data regarding performance of bone graft substitutes is needed.

Introduction. Reinforcement ring with allograft bone is commonly used for acetabular reconstruction of bone defects because it can achieve stable initial fixation of the prosthesis. It is not clear whether the allograft bone can function as a viable host bone and provide long-standing structural support. The purpose of this study was to assess to long-term survival of the reinforcement rings and allograft bone incorporation after acetabular revisions. Methods. We retrospectively reviewed 39 hips (37 patients) who underwent reconstruction of the acetabulum with a Ganz reinforcement ring and allograft bone in revision total hip arthroplasty. There were 18 females and 19 males with a mean age of 55.9 years (35–74 years). The minimum postoperative follow-up period was 10 years (10∼17 years). We assessed the acetabular bone defect using the Paprosky's classification. We determined the rates of loosening of the acetabular reconstructions, time to aseptic loosening, integration of the allograft bone, resorption of the allograft bone, and survival rate. Aseptic loosening of the acetabular component was defined as a change in the cup migration of more than 5 mm or a change in the inclination angle of more than 5° or breakage of the acetabular component at the time of the follow-up. Graft integration was defined as trabecular remodelling crossing the graft-host interface. Resorption of the allograft bone was classified as minor (<1/3), moderate (1/3–1/2) or severe (>1/2). Kaplan-Meier survivorship analysis was performed for aseptic loosening of the acetabular component. The results. The acetabular bone defects were classified as follows: 8 type II hips (4 type IIB, 4 type IIC), and 31 type III hips (17 type IIIA, 14 type IIIB). Fourteen (35.9%) of 39 hips was defined as aseptic loosening of an acetabular component. Loosening was more frequent in type IIIB (57.1%) than in type IIIA hips (29.4%). Mean time to aseptic loosening of the acetabular reconstructions was 6.3 years in type IIIA and from 5 years in type IIIB defects, respectively. Allograft bone incorporation was satisfactory in 66.7% of hips. There was minor bone resorption in 14.3% and moderate bone resorption in 10.2%. In 9 hips (23.1%), severe resorption of the allograft bone was observed and early component loosening was observed in these cases. The survival rate of acetabular component at 10 years of follow-up was 63.6% (95% confidence interval, 49–77%) with aseptic loosening as endpoints. Conclusions. The long-term survival rate of acetabular revision using the reinforcement ring and allograft bone in the reconstruction of severe acetabular bone defects was unsatisfactorily low due to loosening of acetabular components. Because of unfavorable graft incorporation into a host bone, an alternative component and structural support may be employed in the reconstruction of severe acetabular bone defects

Aim. Aim of this monocentric, prospective study was to evaluate the safety, efficacy, clinical and radiographical results at 24-month follow-up (N = 6 patients) undergoing hip revision surgery with severe acetabular bone defects (Paprosky 2C-3A-3B) using a combination of a novel phase-pure betatricalciumphosphate - collagen 3D matrix with allograft bone chips. Method. Prospective follow-up of 6 consecutive patients, who underwent revision surgery of the acetabular component in presence of massive bone defects between April 2018 and July 2019. Indications for revision included mechanical loosening in 4 cases and history of hip infection in 2 cases. Acetabular deficiencies were evaluated radiographically and CT and classified according to the Paprosky classification. Initial diagnosis of the patients included osteoarthritis (N = 4), a traumatic fracture and a congenital hip dislocation. 5 patients underwent first revision surgery, 1 patient underwent a second revision surgery. Results. All patients were followed-up radiographically with a mean of 25,8 months. No complications were observed direct postoperatively. HHS improved significantly from 23.9 preoperatively to 81.5 at the last follow-up. 5 patients achieved a defined good result, and one patient achieved a fair result. No periprosthetic joint infection, no dislocations, no deep vein thrombosis, no vessel damage, and no complaint about limbs length discrepancy could be observed. Postoperative dysmetria was found to be + 0.2cm (0cm/+1.0cm) compared to the preoperative dysmetria of − 2.4 cm (+0.3cm/−5.7cm). Conclusions. Although used in severe acetabular bone defects, the novel phase-pure betatricalciumphosphate - collagen 3D matrixshowed complete resorption and replacement by newly formed bone, leading to a full implant integration at 24 months follow-up and thus represents a promising method with excellent bone regeneration capacities for complex cases, where synthetic bone grafting material is used in addition to autografts

A radiation sterilisation dose (RSD) of 25 kGy is commonly recommended for sterilisation of allograft bone. However, the mechanical and biological performance of allograft bone is gamma dose-dependent. Therefore, this study aimed to apply Method 1 – ISO 11137–2: 2006 to establish a low RSD for frozen bone allografts. Two groups of allograft bones were used: 110 femoral heads (FH) and 130 structural and morselized bones (SMB). The method included the following stages: bioburden determination using 10 FHs and 30 SMBs; verification dose selection using table six in the ISO standard and bioburden; the verification dose was used to irradiate 100 samples from each group; then irradiated bone segments were tested for sterility. The criterion for accepting the RSD as valid is that there must be no more than two non-sterile samples out of 100. The radiation sterilisation dose is then established based on table five, ISO 11137– 2: 2006. The bioburden of both types of frozen allograft was zero. The verification dose chosen was 1.3 kGy. Two hundred bone segments were irradiated at 1.3 kGy. The average delivery gamma dose was 1.23 kGy (with minimum dose of 1.05 kGy maximum dose of 1.41kGy), which is acceptable according to the ISO standard. Sterility tests achieved 100% sterility. Accordingly, 11 kGy was established as a valid RSD for those frozen bone allografts. A reduction in the RSD from 25 kGy to 11 kGy will significantly improve bone allograft mechanical and biological performance because our data show that this dose level improves the mechanical toughness and osteoclast activity of the allograft by more than 10 and 100 percent, respectively, compared with bone allografts irradiated at 25 kGy. A low RSD of 11 kGy was established for allograft bones manufactured at Queensland Bone Bank by applying dose validation method 1 (ISO 11137.2-2006) that is internationally accepted

Fresh-frozen allograft bone is frequently used in orthopaedic surgery. We investigated the incidence of allograft-related infection and analysed the outcomes of recipients of bacterial culture-positive allografts from our single-institute bone bank during bone transplantation. The fresh-frozen allografts were harvested in a strict sterile environment during total joint arthroplasty surgery and immediately stored in a freezer at −78° to −68° C after packing. Between January 2007 and December 2012, 2024 patients received 2083 allografts with a minimum of 12 months of follow-up. The overall allograft-associated infection rate was 1.2% (24/2024). Swab cultures of 2083 allografts taken before implantation revealed 21 (1.0%) positive findings. The 21 recipients were given various antibiotics at the individual orthopaedic surgeon's discretion. At the latest follow-up, none of these 21 recipients displayed clinical signs of infection following treatment. Based on these findings, we conclude that an incidental positive culture finding for allografts does not correlate with subsequent surgical site infection. Additional prolonged post-operative antibiotic therapy may not be necessary for recipients of fresh-frozen bone allograft with positive culture findings. Chang Gung Medical Foundation

BACKGROUND:. Bony increased-offset reverse shoulder arthroplasty (BIO-RSA) creates a long-necked scapula, providing the benefits of lateralization. Experience with allogenic bone grafting of the glenoid in shoulder arthroplasty is mainly based on its use with total shoulder arthroplasty (TSA). Therefore, our study objectives were: 1) verify if the use of BIO-RSA together with glenoid surface grafting with allogenic bone would provide similar benefits (clinical and functional) as found with autologous bone, 2) determine if allograft could be a good alternative in the absence of (good quality) autograft bone, and 3) to see if the allograft would incorporate with the native glenoid bone. METHODS:. We included 25 patients (19 female, 6 male) in this prospective study. Indications for BIO-RSA were: fracture sequalle (n = 9), revisions (n = 11), 4-part humerus fracture (n = 1), rheumatoid arthritis (n = 1) and cuff tear arthropathy (CTA) with poor humeral head bone quality/osteonecrosis (n = 3). Mean (± SD) age 70 ± 11 years (range, 44–86). Clinical evaluation consisted of ROM, Constant scores, patient satisfaction (Subjective Shoulder Value (SSV)) and noted complications. Radiographic and CT scan evaluation consisted of bone graft healing, bone graft resorption/lysis, glenoid component loosening, inferior scapular notching, spur formation and anterior/posterior scapular notching. Mean follow-up was 34 ± 10 months (24–62). RESULTS:. Mean active mobility improved from 50 ± 39° to 123 ± 33° (50–170°) for anterior elevation, from 2.4 ± 17° to 12.1 ± 16° (−20–40°) for external rotation, and from 1.8 ± 2 to 4.7 ± 3 points (0–8) for internal rotation. Mean Constant scores improved from 19 ± 12 to 55 ± 16 points (30–83) and from 26 ± 16% to 77 ± 24% (40–111%). Mean SSV from 21 ± 16% to 65 ± 18% (30–100%). One patient sustained an acromial fracture (treated conservatively) and one patient had breakage of screws and complete glenoid component loosening (revised to a hemi arthroplasty). In 92% of cases (23 of 25) the allograft incorporated completely, partial lysis of the bone graft (n = 5), inferior scapular notching (n = 5), spur formation (n = 7), posterior notching (n = 5). CONCLUSIONS:. BIO-RSA with allograft bone grafting does not provide the same clinical and functional results as with autologous bone grafting. However, it does provide a good alternative in cases where humeral bone stock is not preserved and the allograft bone does incorporate with the native glenoid bone

Background

Revision hip arthroplasty for excessive bone loss because of osteolysis or infection is difficult theme. Bone grafting is essential technique for bone loss and need of allograft is increasing. Recently, many hospital bone banks are established in Japan. The aim of this study is investigate efficacy and safety of allograft in our hospital bone bank.

It is not known if the radiation sterilisation dose (RSD) of 25 kGy affects mechanical properties and biocompability of allograft bone by alteration of collagen triple helix or cross-links. Our aim was to investigate the mechanical and biological performance, cross-links and degraded collagen content of irradiated bone allografts. Human femoral shafts were sectioned into cortical bone beams (40 × 4 × 2 mm) and irradiated at 0, 5, 10, 15, 20, and 25 kGy for three-point bending tests. Corresponding cortical bone slices were used for in vitro determination of macrophage activation, osteoblast proliferation and attachment, and osteoclast formation and fusion. Subsequently, irradiated cortical bone samples were hydrolised for determination of pyridinoline (PYD), deoxypyridinoline (DPD), and pentosidine (PEN) by high performance liquid chromatography (HPLC) and collagen degradation by the alpha chymotrypsin (ï. j. CT) method. Irradiation up to 25 kGy did not affect the elastic properties of cortical bone, but the modulus of toughness was decreased from 87% to 74% of controls when the gamma dose increased from 15 to 25 kGy. Macrophages activation, the proliferation and attachment of osteoblasts on irradiated bone was not affected. Osteoclast formation and fusion were less than 40% of controls when cultured on bone irradiated at 25 kGy, and 80% at 15 kGy. Increasing radiation dose did not significantly alter the content of PYR, DPD or PEN but increased the content of denatured collagen. Cortical allografts fragility increases at doses above 15 kGy. Decreased osteoclast viability at these doses suggests a reduction in the capacity for bone remodelling. These changes were not correlated with alterations in collagen cross-links but in degradation to the collagen secondary structure as evidenced by increased content of denatured collagen

Abstract. Background. The aim of the present experimental study was to analyse vancomycin elution kinetics of nine bone fillers used in orthopaedic and trauma surgery over 42 consecutive days. Methods. Two allograft bone chips (carriers 1 and 2), a calcium-sulfate matrix (carrier 3), a hydroxyapatite/calcium-sulphate composite (carrier 4), four bone cements (carriers 5-8) and a pure tricalcium phosphate matrix (carrier 9), either already contained vancomycin, or were mixed with it following manufacturer's recommendations. Over 42 days, half of elution medium was substituted by the same amount of PBS at 9 distinct time points. Vancomycin concentration in obtained samples were measured with a kinetic microparticle immunoassay, and masses consecutively calculated. To enhance comparability between carriers analysed, vancomycin mass released related to overall mass within each probe was determined. Notably, elution kinetics of carriers 1 to 4 have been published previously. Results. All carriers initially released high vancomycin masses, followed by constant reduction later into the experiment. Mean initial vancomycin masses released after 4 hours were highest for carriers 1 (337.7 ± 76.2 mg), 9 (68.4 ± 4.9 mg), and 2 (49.0 ± 54.6 mg). From prefinal (35 days) to last measurement (42 days) carriers 2 (8.6 ± 4.8 mg), 1 (2.4 ± 1.0 mg), and 5 (0.1 ± 0.1 mg) had released highest vancomycin masses. Notably, all five bone cements tested only released a small percental amount of their total mass up to the last measurement (42 days; 2.1% – 9.3%), whilst allografts and resorbable synthetic bone fillers discarded high percental values (22.5% – 79.2%). Conclusions. Elution kinetics differ between 9 antibiotic-loaded bone fillers, with high vancomycin masses released by allografts and resorbable bone fillers over time. Transferred to clinical practice, these may be favoured over bone cements in case prolonged and high antibiotic release is warranted rather than mechanical stability

Aim. infected segmental bone defect (ISBD) is frequent in developing countries. The aim of this study was to assess the efficacy of the Masquelet technique in the treatment of ISBD in a low-resource setting. Patients and Method. We performed a prospective cohort study during the period from 2018 to 2022. Patients with infected bone defect of long bones were included. Management protocol consisted of two stages in all patients. The first stage consisted in debridement, tissues biopsy for microbiological culture, stabilization with external fixator and defect filling with gentamicin cement spacer. The second stage consisted of reconstruction using a cancellous bone autograft alone, or a mixture of autograft with allograft (demineralized bone matrix + tricalcium phosphate) and 1 gram of vancomycin powder. All patients were followed-up for at least one year. The results were assessed based on both objective (clinical and radiographic evaluation) and subjective (limb function and patient satisfaction) criteria. Main outcomes were bone union, reoperation and failure rates, union time, and limb function. Results. We included 31 patients in this study (80.6% men), with a median age of 35 [9 – 80] years. The tibia was affected in 12 cases and the femur in 15 cases. The median size of bone defect was 4 [1.5 – 12] cm. The most prevalent microorganisms were Klebsiella pneumoniae and Staphylococcus aureus. The mean interval between both stages was 14 (8 – 36) weeks and the median follow-up period after the second stage was 20 [12-62] months. External fixation was used in both stages in 25(80%) cases. Bone union was achieved in 26 (83.8%) patients of whom 24 without recurrence of infection, over a median time of 9 [6 – 16] months. All patients with a mixed graft (allograft and autograft) impregnated with local antibiotics achieved bone union. Two patients needed reoperation for relapse of infection between both stages, and subsequently achieved bone union without recurrence of infection. There were three cases of failure related to persistent infection or insufficient fixation stability in the second stage. Conclusions. Masquelet technique is a reliable procedure that can be safely performed in limited resources settings with satisfactory results. The mixture of autograft and allograft when available, all mixed with vancomycin seems to give promising results

Purpose. The aim of this study was to compare the clinical outcomes of the revision TKA in which trabecular metal cones and femoral head allografts were used for large bone defect. Method. Total 53 patients who have undergone revision TKA from July 2013 to March 2017 were enrolled in this study. Among them, 24 patients used trabecular metal cones, and 29 patients used femoral head allografts for large bone defect. There were 3 males and 21 females in the metal cone group, while there were 4 males and 25 females in the allograft group. The mean age was 70.2 years (range, 51–80) in the femoral head allograft group, while it was 79.1 years (range, 73–85) in the metal cone group. Bone defect is classified according to the AORI classification and clinical outcomes were evaluated with Visual Analogue Scale (VAS), Hospital Special Surgery-score (HSS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS), and ROM. Operation time was also evaluated. We used radiographs to check complications such as migration or loosening. We took follow-up x-rays and 3D CT of the patients, to assess the mean bone union period. Shapiro-Wilk test was done to check normality and Student T-test and Mann Whitney U-test were done for comparison between two groups. Result. The mean follow-up period was 3 .75 years (Range; 2.1 ∼ 5.75). The pre-op scores did not show significant difference. The mean VAS in the allograft and trabecular metal cone groups was 2.1 ± 0.87 and 1.8 ± 0.53, respectively (p = 0.16). The mean HSS score were 76.3 ± 5.51 and 79.2 ± 4.12 respectively (p = 0.13) and the mean WOMAC scores were 15.1 ± 3.25 and 14.8 ± 3.31 respectively (p = 0.06), and the mean KOOS scores were 27.8 ± 4.77 and 25.5 ± 4.84, respectively (p = 0.07). The mean ROM ranges were 100.6 ± 17.54 and 101.3 ± 19.22, respectively (p = 0.09). But the mean operation time of the allograft and trabecular metal cone groups was 137 minutes (Range; 111–198) and 102minutes (Range; 93 −133) (p=0.02) respectively, which showed statistical significance. In follow-up x-rays, no migration or loosening of the implants, osteolysis and other complications were found in both groups. In follow-up 3D CT, osteointegration was seen at the trabecular metal cone site, host bone being interpreted to the host bone. The allograft group showed fibrous and stable union in follow-up 3D CT. Conclusion. According to this study, in case of revision TKA with large bone defect, using whether allograft or trabecular metal cones did not affect the clinical outcomes. However, operation time was significantly shorter in trabecular metal cone group, therefore, in patients with poor general condition along with severe underlying diseases, usage of trabecular metal cone would be a better choice to shorten operation time and ease postoperative care. Keywords. Revision TKA, metal cone, allograft, bone defect. For any figures or tables, please contact authors directly

Introduction. The reconstructive hip surgeon is commonly faced with complex cases where severe bone loss makes conventional revision techniques difficult or impossible. This problem is likely to increase in future, as there is a good correlation between the degree of bone loss seen and number of previous total hip operations. In such situations, one alternative is the use impaction allografting with cement. This has captured the attention of the orthopaedic community because of its potential for reconstituting femoral bone stock. History. The first clinical reports of impaction allografting on the femoral side were in relation to revision with cementless stems. The use of morselised bone with cement on the femoral side was first reported by the Exeter group. Biology. The great enthusiasm with which this technique has been received is related to its biological potential to increase bone stock. The rapid revascularisation, incorporation and remodelling of morselised compacted cancellous allograft differs dramatically from structural allografting where bone ingrowth usually is limited to 2–3mm. Histological evidence for bony reconstitution has been presented from postmortem retrievals, and from biopsies at the time of trochanteric wire removal. The Technique of Impaction Allografting. Type of bone: The size of the bone chips used as morselised allograft is important. The graft behaves as a friable aggregate and its resistance to complex forces depends on grading, normal load and compaction. It is recommended that particles of 3–5mm in diameter make up the bulk of the graft. A bone slurry, such as that produced by blunted bone mills, or by the use of acetabular reamers or high speed burrs would not give satisfactory stability. A wide range of particles sizes is recommended in order to achieve the greatest stability. Future considerations will include the potential for either adding biomaterials to the allograft, or ultimately substituting it completely. The cement mantle: A satisfactory cement mantle is required to ensure the longevity of any cemented stem. The primary determinant of cement mantle thickness is the differential between the graft impactors and the final stem. All femoral impaction systems require careful design to achieve a cement mantle that is uninterrupted in its length and adequate in its thickness. Stem design: The technique of impaction allografting on the femoral side was first and most successfully reported using a highly polished stem with a double tapered geometry and no collar. It is thought to be ideal for this technique as it can subside within the cement mantle, thus generating hoop stresses on the cement which creeps, potentially maintaining physiological loads on the supporting bone. The extension of this technique to other stems has led to some controversy. Confounding factors such as surgical technique, the impaction system available, the type and size of allograft bone used, and the extent of the pre-operative bone loss, will undoubtedly continue to influence such comparisons. It appears that the exact stem configuration may not be as critical as its surface finish, the amount of graft impaction possible and the cement mantle produced. The introduction of longer stems and impactors in the last decade has undoubtedly further increased the scope of this technique. Conclusion. Impaction allografting is the only technique currently available that reverses the loss of bone stock seen in a revision hip arthroplasty. Moreover, this technique does not sacrifice host tissue, and could facilitate further surgery

Femoral revision in cemented THA might include some technical difficulties, based on loss of bone stock and cement removal, which might lead to further loss of bone stock, inadequate fixation, cortical perforation or consequent fractures. Femoral impaction grafting, in combination with a primary cemented stem, allows for femoral bone restoration due to incorporation and remodelling of the allograft bone by the host skeleton. Historically it has been first performed and described in Exeter in 1987, utilizing a cemented tapered polished stem in combination with morselised fresh frozen bone grafts. The technique was refined by the development of designated instruments, which have been implemented by the Nijmegen group from Holland. Indications might include all femoral revisions with bone stock loss, while the Endo-Clinic experience is mainly based on revision of cemented stems. Cavitary bone defects affecting meta- and diaphysis leading to a wide or so called “drain pipe” femora, are optimal indications for this technique, especially in young patients. Contraindications are mainly: septical revisions, extensive circumferential cortical bone loss and noncompliance of the patient. Generally, the technique creates a new endosteal surface to host the cemented stem by reconstruction of the cavitary defects with impacted morselised bone graft. This achieves primary stability and restoration of the bone stock. It has been shown, that fresh frozen allograft shows superior mechanical stability than freeze-dried allografts. Incorporation of these grafts has been described in 89%. Technical steps include: removal of failed stem and all cement, reconstruction of segmental bone defects with metal mesh (if necessary), preparation of fresh frozen femoral head allografts with bone mill, optimal bone chip diameter 2–5 mm, larger chips for the calcar area (6–8 mm), insertion of an intramedullary plug including central wire, 2 cm distal the stem tip, introduction of bone chips from proximal to distal, impaction started by distal impactors over central wire, then progressive larger impactors proximal, insertion of a stem “dummy” as proximal impactor and space filler, removal of central wire, retrograde insertion of low viscosity cement (0.5 Gentamycin) with small nozzle syringe, including pressurization, and insertion of standard cemented stem. The cement mantle is of importance, as it acts as the distributor of force between the stem and bone graft and seals the stem. A cement mantle of at least 2 mm has shown favorable results. Post-operative care includes usually touch down weightbearing for 6–8 weeks, followed by 4–6 weeks of gradually increased weightbearing with a total of 12 weeks on crutches. Relevant complications include mainly femoral fractures due to the hardly impacted allograft bone. Subsidence of tapered polished implants might be related to cold flow within the cement mantle, however, could also be related to micro cement mantle fractures, leading to early failure. Subsidence should be less than 5 mm. Survivorship with a defined endpoint as any femoral revision after 10-year follow up has been reported by the Exeter group being over 90%, while survivorship for revision as aseptic loosening being above 98%. Within the last years various other authors and institutions reported about similar excellent survivorships, above 90%. In addition, a long-term follow up by the Swedish arthroplasty registry in more than 1180 patients reported a cumulative survival rate of 94% after 15 years. Impaction grafting might technically be more challenging and more time consuming than cement-free distal fixation techniques. It, however, enables a reliable restoration of bone stock which might especially become important in further revision scenarios in younger patients

Femoral revision in cemented THA might include some technical difficulties, based on loss of bone stock and cement removal, which might lead to further loss of bone stock, inadequate fixation, cortical perforation or consequent fractures. Femoral impaction grafting, in combination with a primary cemented stem, allows for femoral bone restoration due to incorporation and remodeling of the allograft bone by the host skeleton. Historically, it has been first performed and described in Exeter in 1987, utilizing a cemented tapered polished stem in combination with morselised fresh frozen bone grafts. The technique was refined by the development of designated instruments, which have been implemented by the Nijmegen group from Holland. Indications might include all femoral revisions with bone stock loss, while the ENDO-Klinik experience is mainly based on revision of cemented stems. Cavitary bone defects affecting meta- and diaphysis leading to a wide or so called “drain pipe” femora, are optimal indications for this technique, especially in young patients. Contraindications are mainly: septical revisions, extensive circumferential cortical bone loss and noncompliance of the patient. Generally the technique creates a new endosteal surface to host the cemented stem by reconstruction of the cavitary defects with impacted morselised bone graft. This achieves primary stability and restoration of the bone stock. It has been shown, that fresh frozen allograft shows superior mechanical stability than freeze-dried allografts. Incorporation of these grafts has been described in 89%. Technical steps include: removal of failed stem and all cement, reconstruction of segmental bone defects with metal mesh (if necessary), preparation of fresh frozen femoral head allografts with bone mill, optimal bone chip diameter 2 – 5 mm, larger chips for the calcar area (6 – 8 mm), insertion of an intramedullary plug including central wire, 2 cm distal to the stem tip, introduction of bone chips from proximal to distal, impaction started by distal impactors over central wire, then progressively larger impactors proximal, insertion of a stem “dummy” as proximal impactor and space filler, removal of central wire, retrograde insertion of low viscosity cement (0.5 Gentamycin) with small nozzle syringe, including pressurization, insertion of standard cemented stem. The cement mantle is of importance, as it acts as the distributor of force between the stem and bone graft and seals the stem. A cement mantle of at least 2 mm has shown favorable results. Originally the technique is described with a polished stem. We use standard brushed stems with comparable results. Postoperative care includes usually touch down weight bearing for 6–8 weeks, followed by 4–6 weeks of gradually increased weightbearing with a total of 12 weeks on crutches. Survivorship with a defined endpoint as any femoral revision after 10 year follow up has been reported by the Exeter group being over 90%. While survivorship for revision related to aseptic loosening being above 98%. Within the last years various other authors and institutions reported similar excellent survivorships, above 90%. In addition a long term follow up by the Swedish arthroplasty registry in more than 1180 patients reported a cumulative survival rate of 94% after 15 years. Impaction grafting might technically be more challenging and more time consuming than cement free distal fixation techniques. It, however, enables a reliable restoration of bone stock which might become important in further revision scenarios in younger patients

Introduction:. The reconstructive hip surgeon is commonly faced with complex cases where severe bone loss makes conventional revision techniques difficult or impossible. This problem is likely to increase in future, as there is a good correlation between the degree of bone loss seen and number of previous total hip operations. In such situations, one alternative is the use of impaction allografting with cement. History:. The first clinical reports of impaction allografting on the femoral side were in relation to revision with cementless stems. The use of morselised bone with cement on the femoral side was first reported by the Exeter group. Biology:. The great enthusiasm with which this technique has been received is related to its biological potential to increase bone stock. The rapid revascularization, incorporation and remodeling of morselised compacted cancellous allograft differs dramatically from structural allografting where bone ingrowth usually is limited to 2mm to 3mm. Histological evidence for bony reconstitution has been presented from postmortem retrievals, and from biopsies at the time of trochanteric wire removal. Type of bone:. The size of the bone chips used as morselised allograft is important. The graft behaves as a friable aggregate and its resistance to complex forces depends on grading, normal load and compaction. It is recommended that particles of 3–5mm in diameter make up the bulk of the graft. A bone slurry, such as that produced by blunted bone mills, or by the use of acetabular reamers or high speed burrs would not give satisfactory stability. A wide range of particle sizes is recommended in order to achieve the greatest stability. The cement mantle:. A satisfactory cement mantle is required to ensure the longevity of any cemented stem. The primary determinant of cement mantle thickness is the differential between the graft impactors and the final stem. All femoral impaction systems require careful design to achieve a cement mantle that is uninterrupted in its length and adequate in its thickness. Stem design:. The technique of impaction allografting on the femoral side was first and most successfully reported using a highly polished stem with a double tapered geometry and no collar. It is thought to be ideal for this technique as it can subside within the cement mantle, thus generating hoop stresses on the cement which creeps, potentially maintaining physiological loads on the supporting bone. The extension of this technique to other stems has led to some controversy. Confounding factors such as surgical technique, the impaction system available, the type and size of allograft bone used, and the extent of the preoperative bone loss, will undoubtedly continue to influence such comparisons. It appears that the exact stem configuration may not be as critical as its surface finish, the amount of graft impaction possible and the cement mantle produced. The introduction of longer stems and impactors in the last decade has undoubtedly further increased the scope of this technique. Conclusion:. Impaction allografting is the only technique currently available that reverses the loss of bone stock seen in a revision hip arthroplasty. Moreover, this technique does not sacrifice host tissue, and could facilitate further surgery. Impaction allografting, performed with great attention to detail using appropriate equipment, represents an exciting reconstructive solution for contained femoral defects

The reconstructive hip surgeon is commonly faced with complex cases where severe bone loss makes conventional revision techniques difficult or impossible. This problem is likely to increase in future, as there is a good correlation between the degree of bone loss seen and number of previous total hip operations. In such situations, one alternative is the use impaction allografting with cement. This has captured the attention of the orthopaedic community because of its potential for reconstituting femoral bone stock. The first clinical reports of impaction allografting on the femoral side were in relation to revision with cementless stems. The use of morsellised bone with cement on the femoral side was first reported by the Exeter group. The great enthusiasm with which this technique has been received is related to its biological potential to increase bone stock. The rapid revascularisation, incorporation and remodelling of morsellised compacted cancellous allograft differs dramatically from structural allografting where bone ingrowth usually is limited to 2–3mm. Histological evidence for bony reconstitution has been presented from postmortem retrievals, and from biopsies at the time of trochanteric wire removal. The size of the bone chips used as morsellised allograft is important. The graft behaves as a friable aggregate and its resistance to complex forces depends on grading, normal load and compaction. It is recommended that particles of 3–5mm in diameter make up the bulk of the graft. A bone slurry, such as that produced by blunted bone mills, or by the use of acetabular reamers or high speed burrs would not give satisfactory stability. A wide range of particle sizes is recommended in order to achieve the greatest stability. Future considerations will include the potential for either adding biomaterials to the allograft, or ultimately substituting it completely. A satisfactory cement mantle is required to ensure the longevity of any cemented stem. The primary determinant of cement mantle thickness is the differential between the graft impactors and the final stem. All femoral impaction systems require careful design to achieve a cement mantle that is uninterrupted in its length and adequate in its thickness. The technique of impaction allografting on the femoral side was first and most successfully reported using a highly polished stem with a double tapered geometry and no collar. It is thought to be ideal for this technique as it can subside within the cement mantle, thus generating hoop stresses on the cement which creeps, potentially maintaining physiological loads on the supporting bone. The extension of this technique to other stems has led to some controversy. Confounding factors such as surgical technique, the impaction system available, the type and size of allograft bone used, and the extent of the pre-operative bone loss, will undoubtedly continue to influence such comparisons. It appears that the exact stem configuration may not be as critical as its surface finish, the amount of graft impaction possible and the cement mantle produced. Impaction allografting is the only technique currently available that reverses the loss of bone stock seen in a revision hip arthroplasty. Moreover, this technique does not sacrifice host tissue, and could facilitate further surgery. Impaction allografting, performed with great attention to detail using appropriate equipment, represents an exciting reconstructive solution for contained femoral defects. Its role in larger and combined defects remains open to scrutiny. Careful observation and cautious optimism are necessary as further refinements may well improve the predictability of the clinical results and expand the indications for this important addition to the armamentarium of the revision surgeon

Aim. Allograft bone chips used in complex bone reconstruction procedures are associated with an increased infection risk. The perioperative use of systemic cefazolin is standard to prevent infection, but is less effective in the presence of avascular bone grafts. Bone chips have been described as a carrier for local delivery of antibiotics, but impregnation with cefazolin in a prophylactic setting has not been described. We aimed to obtain a prolonged cefazolin release from bone chips to maximize the prophylactic effect. Method. Three types of bone chips were evaluated: fresh frozen, decellularized frozen and decellularized lyophilized. Bone chips were incubated with 20 mg/ml cefazolin or treated with liquid hydrogel containing either 1 mg/ml fibrin or 1 mg/ml collagen and 20 mg/ml cefazolin. The cefazolin hydrogel was distributed in the porous structure by short vacuum treatment. Bone chips with cefazolin but without hydrogel were incubated for 20 min- 4h under atmospheric pressure or under vacuum. Cefazolin elution of bone chips was carried out in fetal bovine serum and analyzed by Ultra Performance Liquid Chromatography – Diode Array Detection. Results. Without hydrogel, cefazolin release was limited to 4 hours. When vacuum was applied during impregnation, elution of cefazolin exceeding the MIC (minimal inhibitory concentration) from decellularized lyophilized bone chips was obtained for 36 hours. Use of a collagen hydrogel and vacuum treatment resulted in a high concentration at 24 hours, but did not support prolonged release for any of the three types of tested bone chips. In contrast, combination of decellularized frozen bone chips with fibrin hydrogel resulted in an initial release of 533 μg/ml, declining to the MIC at 72 hours, while no longer measurable after 92 hours. Such elution profile is desirable, since high initial levels are important to maximize antibacterial action whereas the complete wash out prevents antibiotic resistance. By increasing the cefazolin concentration during impregnation, elution above the MIC could be obtained for 120 hours. Impregnated bone chips stored at −20° C for 3 months performed similarly to freshly impregnated bone chips. Conclusions. Bone chips processed with the described hydrogel-based impregnation protocol allows tunable delivery of cefazolin for a local prophylactic effect

Femoral revision in cemented THA might include some technical difficulties, based on the loss of bone stock and cement removal, which might lead to further loss of bone stock, inadequate fixation, cortical perforation or consequent fractures. Femoral impaction grafting, in combination with a primary cemented stem, allows for femoral bone restoration by incorporating and remodeling the allograft bone of the host skeleton. Historically, this was first performed and described in Exeter in 1987. Indications might include all femoral revisions with bone stock loss, while the Endo-Clinic experience is mainly based on revision of cemented stems. Nowadays our main indication is the Paprosky Type IIIb and Type IV. Contraindications are mainly: septical revisions, extensive circumferential cortical bone loss and noncompliance of the patient. Generally the technique creates a new endosteal surface to host the cemented stem by reconstruction of the cavitary defects with impacted morselised bone graft. This achieves primary stability and restoration of the bone stock. It has been shown, that fresh frozen allograft shows superior mechanical stability than freeze-dried allografts. Technical steps include: . –. removal of failed stem and all cement rests. –. reconstruction of segmental bone defects with metal mesh (containment). –. preparation of fresh frozen femoral head allografts with bone mill. –. optimal bone chip diameter 2 to 5 mm, larger chips for the calcar area (6–8 mm). –. insertion of an intramedullary plug including central wire, 2 cm distal the stem tip. –. introduction of bone chips from proximal to distal. –. impaction started by distal impactors over central wire, then progressive larger impactors proximal. –. insertion of a stem „dummy“ as proximal impactor and space filler. –. removal of central wire. –. retrograde insertion of bone cement (0.5 Gentamycin) with small nozzle syringe, including pressurisation. –. insertion of standard cemented stem. The cement mantle is of importance as it acts as the distributor of force between the stem and bone graft while sealing the stem. A cement mantle of at least 2 mm has shown favourable results. Post-operative care includes usually touch down weight bearing for 6–8 weeks, followed by 4–6 weeks of gradually increased weightbearing with a total of 12 weeks on crutches. Relevant complications include mainly femoral fractures due to the hardly impacted allograft bone. Subsidence of tapered polished implants might be related to coldflow within the cement mantle, however, it could also be related to micro cement mantle fractures, leading to early failure. Subsidence should be less than 5 mm. Survivorship with a defined endpoint as any femoral revision after 10-year follow-up has been reported by the Exeter group at over 90%. While survivorship for revision defined as aseptic loosening is even greater at above 98%. Within the last years various other authors and institutions reported similar excellent survivorships, above 90%. In addition a long-term follow-up by the Swedish arthroplasty registry in more than 1180 patients reported a cumulative survival rate of 94% after 15 years and 99% with the endpoint aseptic loosening. Impaction grafting is technically more challenging and more time consuming than cement free distal fixation techniques. However, it enables a reliable restoration of bone stock

Fresh-frozen allograft bone is frequently used in orthopaedic surgery. We investigated the incidence of allograft-related infection and analysed the outcomes of recipients of bacterial culture-positive allografts from our single-institute bone bank during bone transplantation. The fresh-frozen allografts were harvested in a strict sterile environment during total joint arthroplasty surgery and immediately stored in a freezer at -78º to -68º C after packing. Between January 2007 and December 2012, 2024 patients received 2083 allografts with a minimum of 12 months of follow-up. The overall allograft-associated infection rate was 1.2% (24/2024). Swab cultures of 2083 allografts taken before implantation revealed 21 (1.0%) positive findings. The 21 recipients were given various antibiotics at the individual orthopaedic surgeon’s discretion. At the latest follow-up, none of these 21 recipients displayed clinical signs of infection following treatment. Based on these findings, we conclude that an incidental positive culture finding for allografts does not correlate with subsequent surgical site infection. Additional prolonged post-operative antibiotic therapy may not be necessary for recipients of fresh-frozen bone allograft with positive culture findings. Cite this article: Bone Joint J 2015;97-B:427–31

Introduction. The reconstructive hip surgeon is commonly faced with complex cases where severe bone loss makes conventional revision techniques difficult or impossible. This problem is likely to increase in future, as there is a good correlation between the degree of bone loss seen and number of previous total hip operations. In such situations, one alternative is the use impaction allografting with cement. This has captured the attention of the orthopaedic community because of its potential for reconstituting femoral bone stock. History. The first clinical reports of impaction allografting on the femoral side were in relation to revision with cementless stems. The use of morselised bone with cement on the femoral side was first reported by the Exeter group. Biology. The great enthusiasm with which this technique has been received is related to its biological potential to increase bone stock. The rapid revascularization, incorporation and remodelling of morselised compacted cancellous allograft differs dramatically from structural allografting where bone ingrowth usually is limited to 2–3 mm. Histological evidence for bony reconstitution has been presented from postmortem retrievals, and from biopsies at the time of trochanteric wire removal. Impaction allografting, performed with great attention to detail using appropriate equipment, represents an exciting reconstructive solution for contained femoral defects. Its role in larger and combined defects remains open to scrutiny. A number of technical issues with regards to allograft preparation and prosthetic design have been resolved over the past decade. The necessary intra-operative precautions are now appreciated, and the high complication rates seen in some centers have been explained in simple terms. Careful observation and cautious optimism are necessary as further refinements may well improve the predictability of the clinical results and expand the indications for this important addition to the armamentarium of the revision surgeon. The technique of impaction allografting of the femur has great potential, and is here to stay as a reconstructive solution to the deficient proximal femur in revision hip arthroplasty. Although many questions remain unanswered, the capacity for impaction allografting to act as a truly biologic augmentation of the proximal femur makes this technique the modern bridge from revision arthroplasty to reconstructive hip surgery